Skip to content
drillr.ai
Sign up

TNYA

Tenaya Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.68
−1.52%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1.3M————
Cost of Revenue(2.2M)8.4M8.5M8.7M8.7M
Gross Profit3.5M(8.4M)(8.5M)(8.7M)(8.7M)
Operating Expenses
R&D Expense61.6M68.6M86.7M98.0M94.5M
SG&A Expense22.4M24.7M20.7M24.5M22.4M
General & Admin Expense22.4M24.7M———
Selling & Marketing Expense—————
Other Expenses25.4M(8.4M)———
Total Operating Expenses109.4M84.9M107.5M122.5M116.9M
Cost and Expenses107.2M93.3M115.9M131.2M125.6M
Operating Income (EBIT)(105.9M)(93.3M)(115.9M)(131.2M)(125.6M)
Non-Operating
Interest Income2.7M2.7M4.7M7.1M2.0M
Interest Expense—————
Net Interest Income2.7M2.7M4.7M7.1M2.0M
Other Non-Op Income/Expense2.7M2.7M4.8M7.1M2.0M
Non-Operating Income (excl Interest)(2.7M)(2.7M)(4.8M)(7.1M)(2.0M)
EBT (Pre-Tax Income)(103.1M)(90.6M)(111.1M)(124.1M)(123.7M)
Income Tax Expense—————
Bottom Line
Net Income(103.1M)(90.6M)(111.1M)(124.1M)(123.7M)
Earnings from Cont. Ops(103.1M)(90.6M)(111.1M)(124.1M)(123.7M)
Earnings from Discont. Ops—————
Bottom Line Net Income(103.1M)(90.6M)(111.1M)(124.1M)(123.7M)
Per Share
Basic EPS($0.53)($0.59)($1.31)($1.68)($2.76)
Diluted EPS($0.53)($0.59)($1.31)($1.68)($2.76)
Revenue Per Share$0.01$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding217.6M153.0M84.8M73.8M44.8M
Diluted Shares Outstanding217.6M153.0M84.8M73.8M44.8M
Profitability Metrics
EBITDA(96.0M)(82.2M)(102.7M)(115.4M)(115.0M)
D&A7.2M8.4M8.5M8.7M8.7M
EBIT(103.1M)(90.6M)(111.1M)(124.1M)(123.7M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026